Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Regenerative Medicine Designation More Useful 'Tool' Than CBER’s Marks Initially Anticipated
May 21 2021
•
By
Sue Sutter
RMAT is a nice tool to have in the regulatory tool belt, CBER's Peter Marks said. • Source: Alamy
More from Cell & Gene Therapies
More from Advanced Technologies